PTEN and colorectal cancer: PTEN mutations were significantly associated with response in ovarian (P = 0.0211) and endometrial tumor cells (P = 0.031), but not in breast cancer or colorectal cancer cell lines (P = 0.278 and P = 0.423, respectively).